Drug maker Innogen closes $120m to tap into China's diabetes market

Drug maker Innogen closes $120m to tap into China's diabetes market

Source: Michael Longmire/Unsplash

Chinese drug maker Innogen Pharmaceutical Technology has raised $120 million in a new funding round to speed up the development and clinical trials of drug candidates, as well as the construction of its production base.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter